APP - amyloid beta precursor protein Gene

Also Known as ABPP

Species: Macaca fascicularis

Gene Type: protein coding
Gene ID: 101926433

About APP

Primary_assembly 3: 20,374,990-20,659,364 forward strand.Macaca_fascicularis_6.0:CM021941.1

This gene has 8 transcripts (splice variants), 280 orthologues and 2 paralogues.

APP Products (6)

mRNA Protein Name
XM_005548883.3 XP_005548940.1 amyloid-beta precursor protein isoform X1
XM_005548888.3 XP_005548945.1 amyloid-beta precursor protein isoform X6
XM_005548886.3 XP_005548943.1 amyloid-beta precursor protein isoform X4
XM_005548884.3 XP_005548941.1 amyloid-beta precursor protein isoform X2
XM_005548887.3 XP_005548944.1 amyloid-beta precursor protein isoform X5
XM_005548885.3 XP_005548942.1 amyloid-beta precursor protein isoform X3

APP Protein Structure

A4_EXTRA

A4_EXTRA: smart00006 (23 - 187)

Kunitz_ABPP-like

Kunitz_ABPP-like: cd22607 (293 - 340)

APP_E2

APP_E2: pfam12925 (365 - 547)

JMTM_Notch_APP

JMTM_Notch_APP: cl41775 (692 - 766)

  • 0
  • 200
  • 400
  • 600
  • 770 a.a.
Protein Preferred Names Protein Names

amyloid-beta precursor protein

  • Alzheimer disease amyloid A4 protein homolog

  • Amyloid beta A4 protein

  • amyloid b-protein

  • amyloid beta (A4) precursor protein

Related Agents

  • Approval
  • Clinical Phase
  • Pre-clinical Phase

Approval

Bioactive Molecules (4)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-10254 Mirdametinib 99.95% Unkown
HY-N0192 Arbutin Inhibitor 99.76% Unkown
HY-14537 Latrepirdine dihydrochloride 99.65% Yes
HY-14862 Latrepirdine 99.51% Yes

Clinical Phase

Bioactive Molecules (8)
Cat. No. Product Name Effect
Purity Phase
HY-103374 Phenserine Inhibitor 99.55% Phase 3
HY-50759 Ispinesib 99.62% Phase 2
HY-106005 MMV390048 Inhibitor 98.85% Phase 2
HY-152846 Flizasertib Inhibitor 99.9% Phase 2
HY-177646 Mivelsiran Inhibitor 95.96% Phase 2
HY-177646A Mivelsiran sodium Inhibitor 95.46% Phase 2
HY-13438 AZD3839 free base Inhibitor 99.97% Phase 1
HY-108041 MGS 0210 Agonist / Phase 1
Inhibitory Antibodies (1)
Cat. No. Product Name Effect
Purity Phase
HY-P99185 Bapineuzumab 96.62% Phase 3

Pre-clinical Phase

Bioactive Molecules (115)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-103490 Takinib 99.68% Unkown
HY-139214 IXA4 Inhibitor 98.92% Unkown
HY-19369 L-685458 99.69% Unkown
HY-P5381 gp91 ds-tat 99.00% Unkown
HY-16009 Buntanetap 99.71% Unkown
HY-123960 Raphin1 Inhibitor 99.74% Unkown
HY-N1472 Levistolide A 99.34% Unkown
HY-129096 IDT307 99.74% Unkown
HY-114174 Fmoc-Ala-Glu-Asn-Lys-NH2 99.55% Unkown
HY-129430 N-Methylprotoporphyrin IX Inhibitor 99.0% Unkown
HY-P6365B APP-018 99.80% Unkown
HY-124832 δ-Secretase inhibitor 11 Inhibitor 99.89% Unkown
HY-120597 SAK3 Activator 99.80% Unkown
HY-13769A TPT-260 Dihydrochloride 98.0% Unkown
HY-135699 TD52 95.0% Unkown
HY-108643 CMPD1 Inhibitor 99.81% Unkown
HY-12989 LDN-91946 Inhibitor 98.04% Unkown
HY-109536B Ammonium polyphosphate, n<20, water solubility>90 g/100 mL / Unkown
HY-50883 BMS 299897 Inhibitor 99.64% Unkown
HY-15294 CZC24832 Inhibitor 99.07% Unkown
HY-18292 ARN2966 Inhibitor 98.78% Unkown
HY-W747599 Ganglioside GQ1b (bovine) sodium ≥98.0% Unkown
HY-12856 GSK503 Inhibitor 99.52% Unkown
HY-123960A Raphin1 acetate Inhibitor 99.93% Unkown
HY-161110 APP degrader-1 Degrader 99.11% Unkown
HY-117924 AUTEN-67 Inducer 97.14% Unkown
HY-161723 LH2-051 Inhibitor 99.85% Unkown
HY-126242S Tyk2-IN-7 Inhibitor 99.58% Unkown
HY-171347 gamma-secretase modulator 6 99.68% Unkown
HY-18010 PCI 29732 Inhibitor 99.59% Unkown
HY-128090A Apstatin TFA Inhibitor 99.57% Unkown
HY-145286 IMPDH2-IN-2 99.89% Unkown
HY-153986 AEP-IN-2 Inhibitor 99.13% Unkown
HY-176036 MS1262 Inhibitor 98.61% Unkown
HY-N3001 Isolinderalactone 98.79% Unkown
HY-135699A TD52 dihydrochloride 99.55% Unkown
HY-139973 OAB-14 99.21% Unkown
HY-50882 ELN318463 Inhibitor 99.45% Unkown
HY-N1414A 3′,6-Disinapoylsucrose Inhibitor 98.88% Unkown
HY-128585 GNE684 Inhibitor 99.08% Unkown
HY-108966 Kushenol C Inhibitor 99.58% Unkown
HY-128464 LL320 Inhibitor 99.91% Unkown
HY-P1378A β-Amyloid (1-43)(human) TFA 95.42% Unkown
HY-RS00863 APP Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-19918A Anatabine dicitrate 99.03% Unkown
HY-16009B Buntanetap L-Tartrate 98.93% Unkown
HY-174367 RUNX1/ETO-IN-1 91.18% Unkown
HY-P1894A β-Amyloid Protein Precursor 770 (135-155) TFA / Unkown
HY-P4553A H-Met-Pro-OH acetate 98.41% Unkown
HY-131068 BACE-1 inhibitor 2 Inhibitor / Unkown
HY-P2551 Biotin-β-Amyloid (17-40) / Unkown
HY-103374A Phenserine tartrate Inhibitor / Unkown
HY-103374B (±)Phenserine Inhibitor / Unkown
HY-105940 IQB-782 / Unkown
HY-107164 Thiomarinol A Inhibitor / Unkown
HY-118243 KMS88009 Inhibitor / Unkown
HY-118245 APP-FUBINACA Agonist / Unkown
HY-118972 TPI-1917-49 Inhibitor / Unkown
HY-125405 AZ3971 Inhibitor / Unkown
HY-125472 LC-1028 Inhibitor / Unkown
HY-126047B (R)-(+)-Anatabine / Unkown
HY-13438A AZD3839 fumarate Inhibitor / Unkown
HY-135618 DHODH-IN-3 Inhibitor / Unkown
HY-136733 Ac-DNLD-CHO Inhibitor / Unkown
HY-139052 III-31-C Inhibitor / Unkown
HY-144739 BACE1-IN-8 Inhibitor / Unkown
HY-144741 BACE1-IN-9 Inhibitor / Unkown
HY-147672 IleRS-IN-1 Inhibitor / Unkown
HY-147674 Isoleucyl tRNA synthetase-IN-2 Inhibitor / Unkown
HY-147927A (S)-Human enteropeptidase-IN-1 Inhibitor / Unkown
HY-149396 FXIIa-IN-1 Inhibitor / Unkown
HY-149396A FXIIa-IN-1 hydrochloride Inhibitor / Unkown
HY-161109 Aβ42-IN-4 / Unkown
HY-161953 O-GlcNAcase-IN-2 Inhibitor / Unkown
HY-168241 Flucopride / Unkown
HY-168859 JNK3 inhibitor-9 Inhibitor / Unkown
HY-169296 IMPDH2-IN-4 Inhibitor / Unkown
HY-176036A MS1262 TFA Inhibitor / Unkown
HY-176271 MAO-B-IN-45 / Unkown
HY-176749 HUP-46 / Unkown
HY-180997 Aβ aggregation-IN-5 Inhibitor / Unkown
HY-182050 YL0441 Inhibitor / Unkown
HY-182367 TMN-OMe Agonist / Unkown
HY-182429 NB-533 Inhibitor / Unkown
HY-183057 GRK2 modulator 1 / Unkown
HY-19846 VRX-03011 Agonist / Unkown
HY-401209 Synucleozid-2.0 Inhibitor 98.01% Unkown
HY-50759A Ispinesib mesylate / Unkown
HY-N12249 7-Deoxy-trans-dihydronarciclasine Inhibitor / Unkown
HY-N13064 2,2′,4,4′-Tetrahydroxychalcone Inhibitor / Unkown
HY-P10163 α-Secretase Substrate II, Fluorogenic / Unkown
HY-P10180 β-Amyloid/A4 Protein Precusor (319-335) / Unkown
HY-P10247 Amyloid precursor C-terminal peptide / Unkown
HY-P10487 APP669-711 / Unkown
HY-P1378 β-Amyloid (1-43)(human) / Unkown
HY-P1729 M-2420 / Unkown
HY-P1894 β-Amyloid Protein Precursor 770 (135-155) / Unkown
HY-P3779 Amyloid 17-42 Inducer / Unkown
HY-P4553 H-Met-Pro-OH / Unkown
HY-P4919 Mca-SEVNLDAEFK(Dnp) / Unkown
HY-P4926 Mca-SEVKMDAEFRK(Dnp)RR-NH2 / Unkown
HY-P5274 BACE1 (485-501) / Unkown
HY-RS00864 App Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS00865 App Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-121817 Sulfiram Inhibitor 96.35% Unkown
HY-128090 Apstatin Inhibitor / Unkown
HY-129133 cis-Miyabenol C / Unkown
HY-133184 Aminogenistein Inhibitor / Unkown
HY-13769 TPT-260 / Unkown
HY-149397 FXIIa-IN-2 Inhibitor / Unkown
HY-180856 APP modulator-1 / Unkown
HY-185723 rG4 WT_AHPC_PEG2 / Unkown
HY-185724 rG4 mut_AHPC_PEG2 Control / Unkown
HY-50882A ELN318463 racemate Inhibitor / Unkown
HY-P4885 Glp-amyloid-β (3-40) peptide (human) / Unkown
Inhibitory Antibodies (5)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-P990301 Anti-Human/Mouse/Rat Amyloid-beta Antibody (MOAB-2) Inhibitor 95% Unkown
HY-P991130 Dalidnetug Ligand 96.686% Unkown
HY-P992157 Anti-APP/Amyloid beta Antibody (3D6) Ligand / Unkown
HY-P992356 GENA-104A16 Inhibitor / Unkown
HY-P992411 MEDI-8490 Inhibitor / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens APP NCBI NCBI:351